Page 20 of 21 – SEC Filing AGREEMENT OF JOINT FILING
This joint filing agreement (this “Agreement”)
is made and entered into as of this 13th day of July, 2016, by and among Viking Global Investors LP, Viking Global Performance
LLC, Viking Global Equities LP, Viking Global Equities II LP, VGE III Portfolio Ltd., Viking Long Fund GP LLC, Viking Long Fund
Master Ltd., Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid
Investments Sub-Master LP, O. Andreas Halvorsen, David C. Ott and Daniel S. Sundheim.
The parties to this Agreement hereby
agree to jointly prepare and file a Schedule 13D with respect to Axovant Sciences Ltd., as well as any amendments thereto, pursuant
to the Securities Exchange Act of 1934, as amended.
IN WITNESS WHEREOF, the parties hereto
have executed this Agreement as of the date first set forth above.
Dated: July 13, 2016
By: /s/O. Andreas Halvorsen By: O. Andreas Halvorsen – individually and as an Executive Committee
Member of VIKING GLOBAL PERFORMANCE LLC, on behalf of itself and VIKING GLOBAL EQUITIES LP, VIKING GLOBAL EQUITIES II LP and VGE
III PORTFOLIO LTD., and as an Executive Committee Member of Viking Global Partners LLC, on behalf of VIKING GLOBAL INVESTORS LP,
and as an Executive Committee Member of VIKING LONG FUND GP LLC, on behalf of itself and VIKING LONG FUND MASTER LTD., and as an
Executive Committee Member of VIKING GLOBAL OPPORTUNITIES GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES PORTFOLIO
GP LLC and VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP
By: /s/David C. Ott By: David C. Ott – individually and as an Executive Committee Member
of VIKING GLOBAL PERFORMANCE LLC, on behalf of itself and VIKING GLOBAL EQUITIES LP, VIKING GLOBAL EQUITIES II LP and VGE III PORTFOLIO
LTD., and as an Executive Committee Member of Viking Global Partners LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as Executive
Committee Member of VIKING LONG FUND GP LLC, on behalf of itself and VIKING LONG FUND MASTER LTD., and as an Executive Committee
Member of VIKING GLOBAL OPPORTUNITIES GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC and VIKING GLOBAL
OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP
Page 20 of 21 Pages
AGREEMENT OF JOINT FILING
This joint filing agreement (this “Agreement”)
is made and entered into as of this 13th day of July, 2016, by and among Viking Global Investors LP, Viking Global Performance
LLC, Viking Global Equities LP, Viking Global Equities II LP, VGE III Portfolio Ltd., Viking Long Fund GP LLC, Viking Long Fund
Master Ltd., Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid
Investments Sub-Master LP, O. Andreas Halvorsen, David C. Ott and Daniel S. Sundheim.
The parties to this Agreement hereby
agree to jointly prepare and file a Schedule 13D with respect to Axovant Sciences Ltd., as well as any amendments thereto, pursuant
to the Securities Exchange Act of 1934, as amended.
IN WITNESS WHEREOF, the parties hereto
have executed this Agreement as of the date first set forth above.
Dated: July 13, 2016
| By: /s/O. Andreas Halvorsen | |
| By: O. Andreas Halvorsen – individually and as an Executive Committee | |
| By: /s/David C. Ott | |
| By: David C. Ott – individually and as an Executive Committee Member | |
| Page 20 of 21 Pages |
Follow Sio Gene Therapies Inc. (NASDAQ:SIOX)
Follow Sio Gene Therapies Inc. (NASDAQ:SIOX)
Receive real-time insider trading and news alerts





